Largest Biotechnology Industry Companies
There are 646 Biotechnology companies.
All industries.
Total Market Cap: $1.19T
Rank | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (646 stocks) | +8.47% | 20.86 | 16.03 | 0.26 | -1.98% | 5.00% | +56.62% | +10.77% | 0.90 | |||||
1 | VRTX | Vertex Pharmaceuticals Inc | $444.93 | $111B | +9.89% | 25.57 | 23.42 | 1.68 | 3.35% | N/A | 74 | +23.32% | $549 | +17.96% | 0.51 |
2 | VRNA | Verona Pharma Plc | $106.91 | $78B | N/A | N/A | N/A | N/A | -0.09% | N/A | N/A | N/A | N/A | +71.15% | N/A |
3 | REGN | Regeneron Pharmaceuticals Inc | $612.14 | $63B | +20.31% | 14.36 | 13.64 | 79.72 | 8.01% | 0.59% | 72 | +36.13% | $833 | +3.14% | 0.63 |
4 | ARGX | Argen X SE | $893.52 | $57B | N/A | 24.24 | 33.67 | 0.21 | 1.73% | N/A | 78 | +15.11% | $1.03K | +22.80% | 0.46 |
5 | ALNY | Alnylam Pharmaceuticals Inc | $282.85 | $39B | N/A | 123.07 | 30.30 | 0.51 | 1.21% | N/A | 74 | +55.04% | $439 | +11.16% | 0.80 |
6 | ONC | BeiGene Ltd | $264.48 | $31B | N/A | 58.89 | 42.19 | N/A | 2.77% | N/A | 81 | +55.91% | $412 | -5.17% | 0.53 |
7 | RVMD | Revolution Medicines Inc | $153.87 | $29B | +30.12% | N/A | N/A | N/A | -3.71% | N/A | 78 | +21.72% | $187 | +34.80% | 1.09 |
8 | RPRX | Royalty Pharma plc - Class A | $54.87 | $24B | N/A | 27.78 | 45.25 | 1.28 | 10.97% | 1.62% | 80 | +7.98% | $59 | +6.69% | 0.27 |
9 | BNTX | BioNTech SE | $90.54 | $22B | N/A | N/A | 7.04 | N/A | 0.72% | N/A | 69 | +36.09% | $123 | -15.93% | 0.95 |
10 | INCY | Incyte Corp | $108.53 | $21B | +27.16% | 14.49 | 14.10 | N/A | 7.20% | N/A | 58 | +0.52% | $109 | +5.60% | 0.59 |
11 | ROIV | Roivant Sciences Ltd | $30.04 | $21B | N/A | N/A | N/A | N/A | -3.75% | N/A | 76 | +29.96% | $39 | 0.00% | 0.93 |
12 | INSM | Insmed Inc | $97.85 | $20B | +12.24% | N/A | 16.37 | 1.09 | -4.63% | N/A | 80 | +101.96% | $198 | +26.70% | 0.81 |
13 | MRNA | Moderna Inc | $49.91 | $18B | N/A | N/A | 23.04 | N/A | -8.78% | N/A | 48 | -13.24% | $43 | -24.79% | 1.40 |
14 | GMAB | Genmab | $25.08 | $16B | -30.81% | 118.15 | 14.81 | 1.62 | 0.88% | N/A | 70 | +46.81% | $37 | -10.69% | 0.62 |
15 | JAZZ | Jazz Pharmaceuticals plc | $230.56 | $14B | N/A | N/A | 12.58 | 0.96 | 8.93% | N/A | 78 | +11.01% | $256 | +4.34% | 0.72 |
16 | ASND | Ascendis Pharma A/S | $218.06 | $14B | N/A | 23.50 | 13.48 | N/A | 0.37% | N/A | 80 | +36.31% | $297 | +10.16% | 0.47 |
17 | EXEL | Exelixis Inc | $53.13 | $13B | +72.24% | 16.60 | 16.92 | 0.43 | 6.88% | N/A | 61 | -7.77% | $49 | +18.48% | 0.53 |
18 | BBIO | BridgeBio Pharma Inc | $66.80 | $13B | -3.14% | N/A | N/A | N/A | -3.37% | N/A | 79 | +53.76% | $103 | +0.94% | 1.06 |
19 | AXSM | Axsome Therapeutics Inc | $255.17 | $13B | +6.89% | N/A | 333.33 | N/A | -0.56% | N/A | 77 | +7.88% | $275 | +30.46% | 0.66 |
20 | IONS | Ionis Pharmaceuticals Inc | $73.28 | $12B | -21.44% | N/A | 90.91 | N/A | -7.98% | N/A | 78 | +39.43% | $102 | +14.16% | 0.73 |
21 | MDGL | Madrigal Pharmaceuticals Inc | $480.77 | $11B | +23.26% | N/A | 666.67 | N/A | -2.52% | N/A | 73 | +41.17% | $679 | +34.89% | 0.73 |
22 | BMRN | Biomarin Pharmaceutical Inc | $55.95 | $11B | -20.33% | 40.22 | 11.24 | 0.71 | 7.07% | N/A | 75 | +57.02% | $88 | -7.47% | 0.68 |
23 | SMMT | Summit Therapeutics Inc | $14.01 | $10B | N/A | N/A | 3.72 | N/A | -3.80% | N/A | 60 | +103.57% | $29 | +16.18% | 1.77 |
24 | ARWR | Arrowhead Pharmaceuticals Inc | $74.52 | $9.94B | +15.23% | N/A | 111.11 | N/A | -0.51% | N/A | 78 | +18.32% | $88 | -3.36% | 1.66 |
25 | NUVL | Nuvalent Inc - Class A | $123.25 | $9.70B | N/A | N/A | N/A | N/A | -3.22% | N/A | 80 | +3.95% | $128 | 0.00% | 0.99 |
26 | KRYS | Krystal Biotech Inc | $317.97 | $9.20B | N/A | 40.45 | 46.30 | 0.51 | 2.58% | N/A | 72 | +1.51% | $323 | +37.48% | 0.95 |
27 | HALO | Halozyme Therapeutics Inc | $69.50 | $8.36B | +20.06% | 23.83 | 9.62 | N/A | 7.99% | N/A | 67 | +20.72% | $84 | +9.90% | 0.62 |
28 | CYTK | Cytokinetics Inc | $70.15 | $8.27B | +27.73% | N/A | 117.65 | N/A | -6.64% | N/A | 79 | +49.25% | $105 | +26.27% | 0.77 |
29 | TECH | Bio-Techne Corp | $54 | $8.22B | -10.07% | 74.88 | 26.45 | 0.75 | 3.28% | 0.59% | 71 | +14.24% | $62 | -13.22% | 1.13 |
30 | CORT | Corcept Therapeutics Inc | $82.91 | $8.16B | -8.23% | 185.65 | 102.04 | 0.81 | 1.47% | N/A | 75 | +6.14% | $88 | +30.89% | 1.32 |
31 | ABVX | Abivax | $96.55 | $7.77B | +25.56% | N/A | N/A | N/A | -3.92% | N/A | 84 | +54.42% | $149 | 0.00% | 1.82 |
32 | MTSR | Metsera Inc | $70.50 | $7.40B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
33 | IBRX | ImmunityBio Inc | $7.10 | $7.31B | -9.78% | N/A | N/A | N/A | -4.09% | N/A | 83 | +83.10% | $13 | -13.81% | 1.61 |
34 | TGTX | TG Therapeutics Inc | $49.52 | $7.14B | N/A | 15.67 | 38.02 | 0.01 | -0.20% | N/A | 66 | -3.07% | $48 | +5.27% | 0.81 |
35 | MRUS | Merus N.V | $90 | $6.83B | +12.68% | N/A | N/A | N/A | -4.66% | N/A | N/A | N/A | N/A | +31.21% | N/A |
36 | PTGX | Protagonist Therapeutics Inc | $109.78 | $6.79B | +1.43% | N/A | 23.26 | N/A | -1.74% | N/A | 78 | +8.12% | $119 | +21.71% | 0.24 |
37 | PRAX | Praxis Precision Medicines Inc | $266.58 | $6.70B | -18.18% | N/A | N/A | N/A | -4.21% | N/A | 73 | +135.42% | $628 | -3.01% | 0.92 |
38 | ACLX | Arcellx Inc | $115.07 | $6.67B | N/A | N/A | 61.73 | N/A | -3.19% | N/A | N/A | N/A | N/A | 0.00% | N/A |
39 | PCVX | Vaxcyte Inc | $47.46 | $6.55B | +33.90% | N/A | N/A | N/A | -11.90% | N/A | 75 | +129.67% | $109 | +15.62% | 0.74 |
40 | CDTX | Cidara Therapeutics Inc | $221.38 | $6.49B | N/A | N/A | 5.75 | N/A | -2.05% | N/A | N/A | N/A | N/A | +38.65% | N/A |
41 | LEGN | Legend Biotech Corp | $35.87 | $6.44B | -13.49% | N/A | 238.10 | N/A | -3.67% | N/A | 80 | +60.55% | $58 | -2.37% | 0.54 |
42 | KYMR | Kymera Therapeutics Inc | $86.21 | $6.43B | N/A | N/A | N/A | N/A | -3.80% | N/A | 79 | +38.54% | $119 | +11.24% | 1.53 |
43 | IMVT | Immunovant Inc | $33.62 | $6.36B | +18.52% | N/A | N/A | N/A | -6.41% | N/A | 70 | +36.11% | $46 | +25.64% | 1.26 |
44 | APGE | Apogee Therapeutics Inc | $88.33 | $6.19B | N/A | N/A | N/A | N/A | -3.80% | N/A | 69 | +35.29% | $120 | 0.00% | 1.33 |
45 | CNTA | Centessa Pharmaceuticals plc | $39.72 | $6.14B | N/A | N/A | N/A | N/A | -3.41% | N/A | 59 | +11.20% | $44 | +9.70% | 1.11 |
46 | PTCT | PTC Therapeutics Inc | $75.14 | $6.08B | -16.59% | N/A | 54.05 | 0.81 | -3.72% | N/A | 73 | +25.01% | $94 | +11.34% | 1.03 |
47 | TERN | Terns Pharmaceuticals Inc | $52.95 | $5.95B | N/A | N/A | N/A | N/A | -1.38% | N/A | N/A | N/A | N/A | +24.90% | N/A |
48 | SYRE | Spyre Therapeutics Inc | $80.79 | $5.92B | -2.15% | N/A | N/A | N/A | -3.14% | N/A | 75 | +18.91% | $96 | -13.28% | 1.78 |
49 | RYTM | Rhythm Pharmaceuticals Inc | $88.38 | $5.87B | +17.00% | N/A | N/A | N/A | -2.05% | N/A | 79 | +56.37% | $138 | +33.58% | 0.94 |
50 | MIRM | Mirum Pharmaceuticals Inc | $99.35 | $5.73B | -34.51% | N/A | 2000.00 | N/A | -3.01% | N/A | 82 | +45.89% | $145 | +41.12% | 0.86 |